Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Price to Earnings (2018 - 2026)

Analysis

Sol-Gel Technologies (SLGL) Price to Earnings (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.49
Mar 31, 2026 57.26
Dec 31, 2025 -34.42
Sep 30, 2025 -12.91
Jun 30, 2025 1.90
Mar 31, 2025 1.60
Dec 31, 2024 -4.25
Sep 30, 2024 -22.88
Jun 30, 2024 19.49
Mar 31, 2024 4.07
Dec 31, 2023 -5.69
Sep 30, 2023 -5.98
Jun 30, 2023 -9.76
Mar 31, 2023 8.11
Dec 31, 2022 -17.00
Sep 30, 2022 -32.03
Jun 30, 2022 707.61
Mar 31, 2022 28.69
Dec 31, 2021 12.26
Sep 30, 2021 180.82